Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

Diabetologia. 2016 Jul;59(7):1573-1574. doi: 10.1007/s00125-016-3987-3.

¹ BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Avenue, Glasgow, G12 8TA, UK. naveed.sattar@glasgow.ac.uk.
² BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Avenue, Glasgow, G12 8TA, UK.
³ Department of Cardiology, Gentofte Hospital, Copenhagen, Denmark.
⁴ Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

No abstract available

Publication types